Cargando…
A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice
BACKGROUND: Schistosomiasis is an underestimated neglected tropical disease which affects over 236.6 million people worldwide. According to the CDC, the impact of this disease is second to only malaria as the most devastating parasitic infection. Affected individuals manifest chronic pathology due t...
Autores principales: | Perera, Dilhan J., Hassan, Adam S., Liu, Sunny S., Elahi, Seyyed Mehdy, Gadoury, Christine, Weeratna, Risini D., Gilbert, Rénald, Ndao, Momar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065910/ https://www.ncbi.nlm.nih.gov/pubmed/35500538 http://dx.doi.org/10.1016/j.ebiom.2022.104036 |
Ejemplares similares
-
Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
por: Perera, Dilhan J., et al.
Publicado: (2020) -
Salmonella Typhimurium expressing chromosomally integrated Schistosoma mansoni Cathepsin B protects against schistosomiasis in mice
por: Hassan, Adam S., et al.
Publicado: (2023) -
Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model
por: Hassan, Adam S., et al.
Publicado: (2019) -
Correction: Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model
por: Hassan, Adam S., et al.
Publicado: (2021) -
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
por: Koger-Pease, Cal, et al.
Publicado: (2023)